Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shusuke Yoshikawa

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
The Journal of Dermatology|November 25, 2015
Effective treatments for paronychia caused by oncology pharmacotherapyHiroyuki Goto, Shusuke Yoshikawa, Keita Mori, et al.
The Journal of Dermatology|April 14, 2017
Retrospective evaluation of factors influencing successful skin grafting for patients with skin cancer of the footHiroyuki Goto, Shusuke Yoshikawa, Keita Mori, et al.
European Journal of Dermatology : EJD|November 23, 2017
Nail apparatus melanoma in a Japanese population: a comparative study of surgical procedures and prognoses in a large series of 151 casesDai Ogata, Hisashi Uhara, Arata Tsutsumida, et al.
The Journal of Dermatology|February 6, 2018
Phase 1/2 study assessing the safety and efficacy of dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced cutaneous melanomaNaoya Yamazaki, Arata Tsutsumida, Akira Takahashi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 21, 2019
Adherence to a topical moisturizing preparation for regorafenib-related hand-foot skin reactionJunya Sato, Hiroshi Ishikawa, Satoshi Hamauchi, et al.
Archives of Dermatology|October 20, 2004
Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in JapanToshiaki Saida, Atsushi Miyazaki, Shinji Oguchi, et al.
The American Journal of Dermatopathology|June 1, 2022
Large Cell Neuroendocrine Carcinoma of the Skin/Conjunctiva: A Series of 6 Cases including 1 Combined Case With Squamous Cell CarcinomaKeisuke Goto, Shusuke Yoshikawa, Yoshio Kiyohara, et al.
Investigational New Drugs|September 8, 2017
Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF <sup>V600</sup> mutation-positive solid tumors: a phase 1 studyYutaka Fujiwara, Naoya Yamazaki, Yoshio Kiyohara, et al.
The American Journal of Dermatopathology|April 22, 2024
Loss of p16 Immunoexpression and Deletions of CDKN2A in the Progression of Extramammary Paget Disease: An Immunohistochemical and Genetic Study of 24 Invasive/Metastatic CasesTsubasa Hiraki, Takuma Oishi, Shusuke Yoshikawa, et al.
Journal of Human Genetics|January 11, 2023
A Japanese case of familial malignant melanoma with germline CDK4 variant incidentally diagnosed by cancer genome profilingYoshimi Kiyozumi, Keisuke Goto, Shusuke Yoshikawa, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Dermatology|November 25, 2015
Effective treatments for paronychia caused by oncology pharmacotherapyHiroyuki Goto, Shusuke Yoshikawa, Keita Mori, et al.
The Journal of Dermatology|April 14, 2017
Retrospective evaluation of factors influencing successful skin grafting for patients with skin cancer of the footHiroyuki Goto, Shusuke Yoshikawa, Keita Mori, et al.
European Journal of Dermatology : EJD|November 23, 2017
Nail apparatus melanoma in a Japanese population: a comparative study of surgical procedures and prognoses in a large series of 151 casesDai Ogata, Hisashi Uhara, Arata Tsutsumida, et al.
The Journal of Dermatology|February 6, 2018
Phase 1/2 study assessing the safety and efficacy of dabrafenib and trametinib combination therapy in Japanese patients with BRAF V600 mutation-positive advanced cutaneous melanomaNaoya Yamazaki, Arata Tsutsumida, Akira Takahashi, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 21, 2019
Adherence to a topical moisturizing preparation for regorafenib-related hand-foot skin reactionJunya Sato, Hiroshi Ishikawa, Satoshi Hamauchi, et al.
Archives of Dermatology|October 20, 2004
Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in JapanToshiaki Saida, Atsushi Miyazaki, Shinji Oguchi, et al.
The American Journal of Dermatopathology|June 1, 2022
Large Cell Neuroendocrine Carcinoma of the Skin/Conjunctiva: A Series of 6 Cases including 1 Combined Case With Squamous Cell CarcinomaKeisuke Goto, Shusuke Yoshikawa, Yoshio Kiyohara, et al.
Investigational New Drugs|September 8, 2017
Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF <sup>V600</sup> mutation-positive solid tumors: a phase 1 studyYutaka Fujiwara, Naoya Yamazaki, Yoshio Kiyohara, et al.
The American Journal of Dermatopathology|April 22, 2024
Loss of p16 Immunoexpression and Deletions of CDKN2A in the Progression of Extramammary Paget Disease: An Immunohistochemical and Genetic Study of 24 Invasive/Metastatic CasesTsubasa Hiraki, Takuma Oishi, Shusuke Yoshikawa, et al.
Journal of Human Genetics|January 11, 2023
A Japanese case of familial malignant melanoma with germline CDK4 variant incidentally diagnosed by cancer genome profilingYoshimi Kiyozumi, Keisuke Goto, Shusuke Yoshikawa, et al.
Pageof 8